The apolipoprotein C-III (Gln38Lys) variant associated with human hypertriglyceridemia is a gain-of-function mutation
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Recent cell culture and animal studies have suggested that expression of human apo C-III in the liver has a profound impact on the triacylglycerol (TAG)-rich VLDL 1 production under lipid-rich conditions. The apoC-III Gln38Lys variant was identified in subjects of Mexican origin with moderate hypertriglyceridemia. We postulated that Gln38Lys (C3 QK ), being a gain-of-function mutation, promotes hepatic VLDL 1 assembly/secretion. To test this hypothesis, we expressed C3 QK in McA-RH7777 cells and apoc3 -null mice to contrast its effect with WT apoC-III (C3 WT ). In both model systems, C3 QK expression increased the secretion of VLDL 1 -TAG (by 230%) under lipid-rich conditions. Metabolic labeling experiments with C3 QK cells showed an increase in de novo lipogenesis (DNL). Fasting plasma concentration of TAG, cholesterol, cholesteryl ester, and FA were increased in C3 QK mice as compared with C3 WT mice. Liver of C3 QK mice also displayed an increase in DNL and expression of lipogenic genes as compared with that in C3 WT mice. These results suggest that C3 QK variant is a gain-of-function mutation that can stimulate VLDL 1 production, through enhanced DNL.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
Loss-of-Function Mutations in APOC3, Triglycerides, and Coronary Disease
The TG and HDL Working Group of the Exome Sequencing Project, N. H. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1307095 · Cited by 1,071
Loss-of-Function Mutations in APOC3 and Risk of Ischemic Vascular Disease
Jørgensen, A. B., Frikke-Schmidt, R., Nordestgaard, B. G., & Tybjærg-Hansen, A. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1308027 · Cited by 919
Pollin, T. I., Damcott, C. M., Shen, H., Ott, S. H., Shelton, J., Horenstein, R. B., Post, W., McLenithan, J. C., Bielak, L. F., Peyser, P. A., et al. (2008) · Science · doi:10.1126/science.1161524 · Cited by 688 · cited 1×
“Three loss-of-function variants, namely, Lys58Glu (11), Ala23Thr (10), and Arg19X (21), are associated with a hypotriglyceridemia phenotype and may confer cardioprotective effect.”
BackgroundRole of apoCs in lipoprotein metabolism: functional differences between apoC1, apoC2, and apoC3
Jong, M. C., Hofker, M. H., & Havekes, L. M. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.3.472 · Cited by 539
Ginsberg, H. N., Le, N. A., Goldberg, I. J., Gibson, J. C., Rubinstein, A., Wang-Iverson, P., Norum, R., & Brown, W. V. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112713 · Cited by 424
Graham, M. J., Lee, R. G., Bell, T. A., Fu, W., Mullick, A. E., Alexander, V. J., Singleton, W., Viney, N., Geary, R., Su, J., et al. (2013) · Circulation Research · doi:10.1161/circresaha.111.300367 · Cited by 377 · cited 1×
“Recent studies have shown that inhibition of apoC-III expression, using antisense oligonucleotides, results in lowered plasma TAG in rodents, nonhuman primates, and humans (6).”
BackgroundQin, W., Sundaram, M., Wang, Y., Zhou, H., Zhong, S., Chang, C.-C., Manhas, S., Yao, E. F., Parks, R. J., McFie, P. J., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.203679 · Cited by 107
Self-citationApolipoprotein C-III and hepatic triglyceride-rich lipoprotein production
Yao, Z., & Wang, Y. (2012) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e328352dc70 · Cited by 100 · cited 1×
“The plasma apoC-III concentration is positively correlated with the plasma triacylglycerol (TAG) concentrations, and elevated plasma apoC-III is invariably associated with hypertriglyceridemia (3).”
BackgroundSelf-citation
Cited by
Genetics of hypertriglyceridemia
Dron, J. S., & Hegele, R. A. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00455 · Cited by 244
“Gln38Lys variant that raises TG levels (5) and the common LPL p.”
BackgroundSelf-citationThe Roles of ApoC-III on the Metabolism of Triglyceride-Rich Lipoproteins in Humans
Borén, J., Packard, C. J., & Taskinen, M.-R. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00474 · Cited by 196
“The heterozygote APOC3 LOF mutation Ala43Thr variant has also been associated with impaired lipidation of nascent VLDL particles during their hepatic assembly (103).”
BackgroundLipid-Lowering Agents: Targets Beyond PCSK9
Hegele, R. A., & Tsimikas, S. (2019) · Circulation Research · doi:10.1161/circresaha.118.313171 · Cited by 171
Self-citationApoC-III ASO promotes tissue LPL activity in the absence of apoE-mediated TRL clearance
Ramms, B., Patel, S., Nora, C., Pessentheiner, A. R., Chang, M. W., Green, C. R., Golden, G. J., Secrest, P., Krauss, R. M., Metallo, C. M., et al. (2019) · Journal of Lipid Research · doi:10.1194/jlr.m093740 · Cited by 59
“gain-of-function mutation (Gln38Lys) was associated with increased hepatic de novo lipogenesis measured by upregulation of SREBP-1/2, FAS, ACC1, and CD-36, and FA synthesis (52).”
Metadata
- Authors
- Sundaram, M., Curtis, K. R., Amir Alipour, M., LeBlond, N. D., Margison, K. D., Yaworski, R. A., Parks, R. J., McIntyre, A. D., Hegele, R. A., Fullerton, M. D., & Yao, Z.
- Venue
- Journal of Lipid Research
- Publisher
- Elsevier BV
- Published
- 2017-11
- Volume
- 58
- Issue
- 11
- Pages
- 2188-2196
- ISSN
- 0022-2275 (ISSN-L)
- OpenAlex
- W2753405205
- Cited by
- 38
- References
- 9
- FWCI
- 4.35
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The apolipoprotein C-III (Gln38Lys) variant associated with human hypertriglyceridemia is a gain-of-function mutation. https://app.cochat.ai/papers/10.1194/jlr.m077313
- The paper
- Sundaram, M., Curtis, K. R., Amir Alipour, M., LeBlond, N. D., Margison, K. D., Yaworski, R. A., Parks, R. J., McIntyre, A. D., Hegele, R. A., Fullerton, M. D., & Yao, Z. (2017). The apolipoprotein C-III (Gln38Lys) variant associated with human hypertriglyceridemia is a gain-of-function mutation. Journal of Lipid Research. https://doi.org/10.1194/jlr.m077313
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.